German research journal Springer Nature priced its planned initial public offering, implying a market capitalization of up to ...
Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today ...
Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the ...
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cayson Acquisition Corp (the “Company”) announced today that it closed its initial public offering of 6,000,000 units at $10.00 per unit. The offering ...
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.VANCOUVER, British Columbia, Sept. 23, 2024 (GLOBE ...
Baltic fintech company Eleving Group targets up to 30 million euros ($33.5 million) from its initial public offering, which is set at a price implying an equity value between 160 million and 185 ...
Polish retailer, announced plans for an initial public offering (IPO) on the Warsaw Stock Exchange, marking a significant ...
Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative ...
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Sept. 23, 2024 (GLOBE ...
Cayson Acquisition Corp (the "Company") announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The Company's units ...
New York, NY, Sept. 17, 2024 (GLOBE NEWSWIRE) -- YHN Acquisition I Limited (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit.
Kairos Pharma, Ltd. ("Kairos Pharma" or the "Company") (NYSE American: KAPA), a clinical stage biopharmaceutical company developing cancer therapeutics ...